Special Circular of Drug Controller

SPECIAL CIRCULAR
In view of the repeated news in the media and the misuse of psychotropic drugs by
certain medical shops, it has been decided to enforce maintenance of written
registers at all steps of sales point for sale of psychotropic/other critical drugs sales
from the first sales point to the chemist. This special circular will be have immediate
effect. All Asst Drugs Controllers and Inspectors are instructed to inform all the
depots/C&F Agents/distributors to maintain proper watch on the supply and inform
the supply details with batch/quaintly of such drugs of the ADC and DI before 5th of
every month positively. ADC shall give specific instructions to DI(IB)s and dist DIs to
inspect the shops with unusual purchases of such drugs immediately. ADC will
report such action taken reports to the Head Office every 10th as DO letter to
ADC(IB), O/o DC, TVM positively. The report shall include the names of shops
inspected in the previous month and other shops to be inspected in the current
month too. They can give separate news paper release in each zone to the effect as
the case may be.
Psychotropic drugs
Dextropropoxyvon HCl- ( Proxyvon/Spasmoproxyvon, Corbotayil, Lupion, Sidinol,
Lavagesic, Parvon Spas, Proxytab etc)
Coedine containing cough Syrups (Corex, Codylex Linctus, , Instacodin,
Codocough, Mit’s LInctus Codiine, Phensedyl, Exipion, Tossex, Codo-Q etc)
Pentazocine Injection-(Fortwin, Pentawin, Ridof, Pzocin)
Alprozolam tabs- (Alprax, Alzolam, Restyl, Somnirest, Trika, Zolam etc )
Lorezepam- (Elsipam, Lorazem, Ativan, Larpose, Lorvan, Rosup, Loripam etc)
Nitazepam tabs (Nitravet, Nite, Nitrosun, Nipum etc)
Diazepam-(Valium, Campose)
Haloperidiol-(Serenace,Benzydol, Halidol, Halidace, Seradol

A. Sex Stimulants/Erectyl dysfunction drugs:-
Sildenafil-(Caverta, Penigra, Indigra, Lupigra, Rocky etc)
Tadalafil -(Etalyx, Foreceta, Popup etc)

B. Hormonal drugs
Levonorgestrel tablets-(I-Pill, Pill-72, T-Pill, My-Pill, Easy-2, Divsko, T-Pill 72,
Freelady, Lineclear, Nochance, Novil etc).
Mifepristone- (Mtpill, Mtprost, Mefiprin, Mifegest, Abopill etc)

All Inspectors shall check the movement of such drugs in their inspection. Specific
reports will be forwarded to ADC ,( Ensure that the ,Licensees maintain proper
registers including the Name and Address of Prescriber, Patient, Phone nbr of
Patients), Seal the prescriptions with name, address of seller and date of sale to
avoid repeated purchase) etc. All ADCs will see that C&F and Distributors keep
close track of their stocks, orders etc. Every distributor shall report the sales
quantities of such drugs to the concerned DIs and ADCs before 5th of every month.
Concerned Regional Drugs Inspector/DI(IB) shall coordinate the work with all C&F
Agents in Ernakulam, Kozhikode, Thrissur, where most of the C&F gents are
situated. If the action is not effective as expected, Department will be forced to
restrict the distribution of such drugs with special allotment as followed in Narcotic
Manufactured drugs like Pethidine, Morphine etc. in future.

Drugs Controller.
Dated 4th April, 2011.

Link to the PDF File

Diablife

Each 500mg Tablets contains

PonkurandSalacia reticulata50mg PatakizhanguCyclea peltata50mg KaringaliAcacia catechu50mg NellikkaEmblica officinalis50mg ManjalCurcuma longa50mg NjavalSyzygium cumini50mg ThettamparalStrictnus potatorum50mg CheroolaAerva lanata50mg VengaPterocarpus Marsupium50mg NjerinjilTribulus terrestris 50mg MaramanjalCocosinium fenestratum50mg

Points

•DIAB LIFE Stimulates Liver that ensures Terminal Digestion and Metabolism of Sugar
•DIAB LIFE Stimulates pancreas in order to increase availability of insulin
•DIAB LIFE promotes Peripheral Consumptions of Glucose
•DIAB LIFE provides additional advantage of highly Anti –Oxidant Natural agents that protect cell from oxidative stress.
•DIAB LIFE provides β-cell repair and regeneration.
•DIAB LIFE is highly effective in prevention and postponement of secondary complications.
•DIAB LIFE improves response to OHA therapy and thereby reducing the dosages
Indication & Dosage
Indication: As adjuvant in management of Diabetes Mellitus and cases responding poorly to OHA impaired Glucose tolerance cases
Dosage: 1 to 2 Tablets daily, half an hour before breakfast and dinner or as directed by physician

Anantha Hair Oil is Now Available

Anantha Special Hair Care oil is a miracle oil, effective for treatment of Hairfall, Dandruff, Sinusitis, Tonsillitis, Migraine, Allergic Sneezing, Insomnia (Sleeplessness), Effects of Old Head Injuries

and Baldness (below 40 yrs). Continued use of this oil prevents Baldness and Greying of hair.

Neem Face Pack

Action:

Clears skin and prevents outbreak and recurrence of pimples. Rejuvenates and firms up the skin. Imparts natural glow. Antibacterial purifying Neem Face Pack regulates excess oil secretion, cleans clogged pores and prevents recurrence of pimples. Improves skin texture. Neem, well known for its antibacterial properties, helps in controlling acne and pimples, and their recurrence. When combined with Turmeric, it effectively eliminates acne-causing bacteria. Fuller's Earth (Multani Mitti) cools and soothes the skin.

Indications:

Oily and Pimple-prone skin.

Ingredients Include:

Azadirachta indica (Neem, Nimba)

Panka (Fuller's earth, Multani Mitti)

Curcuma longa (Turmeric, Haridra)

Use Directions:

Apply evenly over cleansed face and neck, avoiding the area around eyes. Allow it to dry for 10-15 minutes. Remove with wet sponge and wash the skin with cool water. Use once or twice a week.

EverYuth Products are now Available

The face is a reflection of one's inner health. Keeping this in mind, Zydus Wellness Ltd. introduced a range of specialty skincare products under the brand name of EverYuth Naturals. These skincare products have been designed to work from within the skin to reflect a clear, beautiful & healthy skin outside.

While having the advantage of being a 'skincare brand from a healthcare company', EverYuth Naturals has always come up with products that are designed keeping in mind the different needs and skin types of women. These products are fortified with the power of natural ingredients that are known for their efficacy and skin nourishing properties. As a result, the brand promises nature's goodness along with the benefits of proven scientific research.

Today, EverYuth Naturals has a strong leadership presence in advanced skincare segments like soap-free face wash, face masks, skin exfoliators amongst others. It also includes specialty dermatologically tested skincare solutions for sun protection, pigmentation and acne. ( www.everyuth.com )

EverYuth has recently forayed into the market of male skincare with the launch EverYuth Menz. With this new range, the brand has filled the vacuum of a basic skin care range for men in the Indian market. In a first of its kind, Everyuth has launched the first scrub for males in India. EverYuth Menz is India’s first comprehensive skincare range designed keeping in mind a man’s rigorous lifestyle and his specific needs. ( www.everyuthmenz.com ) 

The Items are:-

1.Face wash

2.Facial Masks (peel off, packs)

3.Scrubs

4.Sun blocks

5.Winter care - (body lotion and cream)

6.Cleanser and Toner

7.Men skin care - (face washes, sun block, moisturizer, & scrub)

Personalized Skin Care

Cherie Price says she used to be self-conscious about her face breaking out. “Being an actor, it’s very frustrating,” says the Los Angeles resident. “You don’t want to worry about people judging you only by your face.”

Cherie had tried for years to find the right acne treatment. While drugstore shelves offered so many options, she never knew which to choose, and those she tried just weren’t right for her. Then she found out about skin iD™ from Neutrogena Corporation, the first personalized acne solution that’s based on an individual’s skin and lifestyle.

At Neutrogena, one of the Johnson & Johnson Consumer businesses, scientists sought a way to personalize skin care so that each person’s acne treatment would meet his or her particular needs.

“We realized if we could create a way to hear from each person about his or her needs, lifestyle and preferences, we could deliver a more effective, personalized solution,” says Bobby Sheikh, launch Product Director for skin iD™ “Because most stores aren’t equipped to help people through the personalization process, we developed products and a distribution model that sells the skin iD™ product line directly to consumers.

Available exclusively through www.skinid.com or a hotline (866) 742-0201, skin iD™ uses a proprietary, dermatologist-developed skin evaluation. The result is a personalized regimen of consisting of three products: a cleanser and two other products, such as a hydrator and an anti-acne treatment or a toner and a moisturizer.

“It takes you through the steps to define your acne problems,” says Cherie, describing the free skin ID™ evaluation on www.skinid.com. “I liked it a lot. It was very personalized.”

The skin iD™ regimens were tested in a randomized double-blind, placebo-controlled study with industry-leading acne treatments. Five hundred participants were given treatments for eight weeks. “The results were spectacular,” say Sheikh. “We could see that we were improving peoples’ lives.”

“I felt amazing and couldn’t stop looking in the mirror,” says Cherie of her results. “It was a life-changing experience, and I saw my face change for the better.”

Pfizer to Offer Free Public Access to Mental Health Assessment Tools

As part of its commitment to improving the quality of patient care, Pfizer (NYSE: PFE) will make available assessment scales used by physicians and others in the healthcare community to support the evaluation and diagnosis of patients suffering from certain mental disorders. For the first time, these users can directly access and download the Patient Health Questionnaire (PHQ) and the General Anxiety Disorder questionnaire (GAD-7) without copyright restriction and at no charge, providing unprecedented access to these valuable and widely used tools for evaluating certain mental disorders.

"By providing unrestricted access, Pfizer is encouraging broader usage of these important patient assessment aids, which we know will help many healthcare providers and their patients," said Freda C. Lewis-Hall, M.D., senior vice president and chief medical officer at Pfizer. "We are listening to the needs of the mental health community and doing what we can to provide the tools needed to make the best possible healthcare decisions."



The PHQ and GAD scales are quick, efficient, validated methods to assist physicians in diagnosing and monitoring their patients. PHQ-9, a widely used questionnaire, is self-administered and utilizes a scoring method to specifically measure depression-related symptoms. In less than a decade, the PHQ-9 has become commonly used by both clinicians and researchers in large federally sponsored U.S. surveys and has been adopted as a standard measure for depression risk and severity by the Veterans Administration, Department of Defense and several integrated health care systems and public health departments as well as the United Kingdom's National Health Service.



"This is an outstanding example of how both industry and academia can work together to improve the accuracy of diagnosis and support better assessments of treatment response and outcomes," said Darrel A. Regier, M.D., M.P.H., director, Division of Research at the American Psychiatric Association (APA). "In the United States, mental disorders are diagnosed based on the APA's Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). A team of experts is currently working on the fifth edition of the manual, and the PHQ-9 is being considered as one measure to be used for assessing depression severity and treatment response."



According to the National Institute of Mental Health, mental disorders affect an estimated 26.2 percent of Americans ages 18 and older - about one in four adults suffers from a diagnosable mental disorder in a given year. Major depressive disorder, which affects approximately 14.8 million American adults ages 18 and older, is the leading cause of disability in the U.S. for ages 15 to 44. Approximately 40 million American adults ages 18 and older have an anxiety disorder.



More than a decade ago, Pfizer, along with research partners Robert Spitzer, M.D. and Janet Williams, D.S.W. from Columbia University and Kurt Kroenke, M.D. from Indiana University, recognized the need for and supported the independent development of dimensional measurement tools for mental disorders to be used by health care professionals. The four original studies that validated the tools represented nearly 10,000 patients. Between 1999 and 2009, more than 560 publications on these assessment aids have been identified.



"The PHQ-9 and GAD-7 tools really are standard measures for physicians to use," said Kurt Kroenke, M.D., one of the co-developers of the tools from the Department of Medicine, Regenstrief Institute for Health Care and Indiana University School of Medicine. "As depression and anxiety are the most common mental disorders in primary care, the PHQ and GAD instruments are important aids for making accurate diagnoses. They propose a number of scaled treatment options for physicians and patients to consider, including watchful waiting; follow-up for repeating the severity measure; counseling, follow-up and/or pharmacotherapy; and referral to a mental health specialist for psychotherapy and/or collective management, depending on the severity of the mental disorder."



The PHQ and GAD instruments, including different variations and translations in nearly 80 languages, are available at www.phqscreeners.com. The site also provides comprehensive instruction documents, articles, a bibliography and a direct point of contact e-mail address.



Pfizer Inc.: Working together for a healthier worldâ„¢

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com.

SHOP ADDRESS

NEAR SALWA BAKERY
KOLLAM ROAD, KANNANALLOOR
KOLLAM-691576
PH. 0474 2566626(RES), +91 9388566626, +91 9387566626
EMAIL: kanjiramvilamedicals@gmail.com